KFDA notified revaluation results of 307 products to producers.

Published: 1999-11-18 10:56:00

Updated: 1999-11-18 10:56:00

The KFDA has completed the drug revaluation program for 307 products of 65 companies and notified the results to them including the use records by each product and other matters to be complemented.

The KFDA assigned the revaluation works to the task force team (head: Prof. Park Byung-ju, Seoul...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK